ReFerm<sup>®</sup>: a postbiotic fermented oat gruel composition is reducing mast cell degranulation in the colon of patients with irritable bowel syndrome.

Front Med (Lausanne) · 2024 · PMC11255971 · PMID 39026547

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

This observation indicates that ReFerm ® might influence the enteric glial cells, but it did not reach statistical significance, possibly due to the limited number of patients.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.